Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ·Healthcare·Biotechnology
$89.76
-1.78%
Mkt Cap $5.61B
Analyst Ratings
Buy
15
Hold
0
Sell
0
Price Target (49 analysts)
$146.00
Range $118.00 – $185.00
Implied Upside
+62.7%
Consensus $146.00 vs current $89.76
NASDAQ·Healthcare·Biotechnology
$89.76
-1.78%
Mkt Cap $5.61B
Buy
15
Hold
0
Sell
0
Price Target (49 analysts)
$146.00
Range $118.00 – $185.00
+62.7%
Consensus $146.00 vs current $89.76